![](https://static.wixstatic.com/media/356d0cee84164a4cb8304d44630a7ea6.png/v1/fill/w_1920,h_1080,al_c,q_95,usm_0.66_1.00_0.01,enc_avif,quality_auto/356d0cee84164a4cb8304d44630a7ea6.png)
![FCN 9.png](https://static.wixstatic.com/media/19be9b_6386b5c3ee99477783f0d12fcdf75ef8~mv2.png/v1/fill/w_198,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/FCN%209.png)
FlowCytometry Net
(Flow Cytometry Based Knowledge Portal)
Mixed-phenotype acute leukemia (MPAL)
De novo acute leukemia containing separate populations of blasts of more than one lineage (bilineal or bilineage), or a single population of blasts co-expressing antigens of more than one lineage (biphenotypic)
Excludes:
-
Acute myeloid leukemia (AML) with recurrent translocations t(8;21), t(15;17) or inv(16)
-
Leukemias with FGFR1 mutations
-
Chronic myelogenous leukemia (CML) in blast crisis
-
Myelodysplastic syndrome (MDS) related AML and therapy related AML, even if they have MPAL immunophenotype
Score of 2 or more for each of two separate lineages (shown below)
​
![MPAL CRITERIA.gif](https://static.wixstatic.com/media/19be9b_ed78edd01a9e4c75b2d74a3b2f355604~mv2.gif)
MPAL T/Myeloid
​
-
Meets the diagnostic criteria for MPAL with both T and myeloid lineages without Ph+ and MLL rearrangement
-
More often in children, though in adults as well
-
Dimorphic populations, resembling lymphoblasts and myeloblasts, or a single population resembling ALL
-
Other commonly expressed T-lineage markers include CD2, CD7
-
Myeloid markers MPO, CD117, TdT, CD13 and CD33
-
T cell plus myeloid cases may have 2p13 translocations or other unrelated anomalies
CASE 1 MPAL T/M
![MPAL T-M-2.png](https://static.wixstatic.com/media/19be9b_f8eec6cc2cda42acb87e2142e5e7bbf1~mv2.png/v1/fill/w_599,h_409,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/MPAL%20T-M-2.png)
Case 1 shows an example of MPAL with a single blast population (red). In this case, there is cytoplasmic CD3 expression, consistent with T lineage, in conjunction with myeloperoxidase, indicating myeloid lineage. also CD7, CD64, CD33 are positive. This was diagnosed as MPAL, T/myeloid. Figure 1B shows an example of MPAL with two distinct blast populations. The red population is identified as myeloid by the co-expression of two monocytic markers, CD14 (partially expressed) and CD64. The blue population is composed of B lymphoblasts, established by CD19 and CD79a expression. This was diagnosed as MPAL, B/myeloid.
CASE 2 MPAL T/M
![MPAL T-M.png](https://static.wixstatic.com/media/19be9b_675190c9646640ed9167b14253d7f284~mv2.png/v1/fill/w_681,h_365,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/MPAL%20T-M.png)
Case 2 shows an example of MPAL with a single blast population (red). In this case, there is cytoplasmic CD3 expression, consistent with T lineage, in conjunction with myeloperoxidase, indicating myeloid lineage. also CD7, CD15, CD33,CD117 are positive. This was diagnosed as MPAL, T/myeloid.
CASE 3 MPAL T/M
![MPAL T-M-3.png](https://static.wixstatic.com/media/19be9b_db140b7d75544e7eaa847a6dd41c42fc~mv2.png/v1/fill/w_600,h_430,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/MPAL%20T-M-3.png)
Case 3 shows an example of MPAL with a blast population (red). In this case, there is cytoplasmic CD3 expression, consistent with T lineage, in conjunction with myeloperoxidase, indicating myeloid lineage. also CD7, CD5, CD33 are positive. This was diagnosed as MPAL, T/myeloid.
MPAL B/Myeloid
​
-
Meets the diagnostic criteria for MPAL with both B and myeloid lineages without Ph+ and MLL rearrangement
-
B/myeloid acute leukemia accounts for 1% of all leukemias
-
More common in adults but also seen in children
-
Morphology:Dimorphic populations, resembling lymphoblasts and myeloblasts, or a single population resembling ALL
-
Genetics:Multiple different cytogenetic changes have been demonstrated, however none is proven to be specific in this subtype
CASE 1 MPAL B/M
![MPAL B-M.png](https://static.wixstatic.com/media/19be9b_f95dc5025f294656b26285098eadc388~mv2.png/v1/fill/w_600,h_430,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/MPAL%20B-M.png)
Case 1 shows an example of MPAL with two distinct blast populations (red). The red population is identified as myeloid by the co-expression of two myeloid markers MPO, CD33. The other population is composed of B lymphoblasts, established by CD19, cCD22 and CD79a expression. This was diagnosed as MPAL, B/myeloid.
CASE 2 MPAL B/M
![MPAL B-M-2.png](https://static.wixstatic.com/media/19be9b_43973d51698c491da7ea865c046c3d64~mv2.png/v1/fill/w_599,h_315,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/MPAL%20B-M-2.png)
Case 2 shows an example of MPAL with two distinct blast populations MPO and CCD79a positive populations(red). The MPO +population is identified as myeloid by the co-expression of two monocytic markers CD14, CD64 with CD13, CD33 and CD11b. The cCD79a population is composed of B lymphoblasts, established by CD19, cCD22 and CD10 expression. This was diagnosed as MPAL, B/myeloid.
CASE 3 MPAL B/M
![MPAL B-M-3.png](https://static.wixstatic.com/media/19be9b_70750f516b764425830493c61746ba56~mv2.png/v1/fill/w_600,h_203,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/MPAL%20B-M-3.png)
Case 3 shows an example of MPALcase with limited panel have blast populations MPO and CCD79a positive populations(red). The blast population is composed of B lymphoblasts, established by CD19, expression. This was diagnosed as MPAL, B/myeloid.